Figure 4From: NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolatesInhibition of the mortality in mouse of a GAS GT01 clinical isolate by His-IFS. The solution including His-IFS reduced the virulence of the GAS to 42% mortality (5 death/12 trial) compared with 83% (10/12) of the control His-TarC (P = 0.008 for comparison of survival times).Back to article page